These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection. Morris-Jones SD, Easterbrook PJ. J Antimicrob Chemother; 1997 Sep; 40(3):315-8. PubMed ID: 9338481 [No Abstract] [Full Text] [Related]
44. Effect of aerosolized pentamidine prophylaxis on the clinical severity and diagnosis of Pneumocystis carinii pneumonia. Fahy JV, Chin DP, Schnapp LM, Steiger DJ, Schaumberg TH, Geaghan SM, Klein JS, Hopewell PC. Am Rev Respir Dis; 1992 Oct; 146(4):844-8. PubMed ID: 1416408 [Abstract] [Full Text] [Related]
46. [Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations]. Stoehr A, Plettenberg A, Albrecht H, Stellbrink HJ, Meigel W, Begemann F. Med Klin (Munich); 1994 Mar 15; 89(3):132-5. PubMed ID: 8196573 [Abstract] [Full Text] [Related]
48. Safety of pentamidine prophylaxis for Pneumocystis carinii pneumonia on the endocrine pancreatic function in HIV patients. Veyssier P, Cevallos R, Le Fouillé-Ribeyre C, Geffray L, Kaloustian E, Farinotti R. Ann Med Interne (Paris); 1994 Jul 15; 145(7):464-6. PubMed ID: 7864513 [Abstract] [Full Text] [Related]
49. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ. N Engl J Med; 1992 Dec 24; 327(26):1842-8. PubMed ID: 1448121 [Abstract] [Full Text] [Related]
50. Alternative dapsone dosage regimen for prophylaxis of Pneumocystis carinii pneumonia. Gatti G, Fioredda F, Lorusso C, Cruciani M, Bassetti D. Pediatr Infect Dis J; 1996 Feb 24; 15(2):183-4. PubMed ID: 8822303 [No Abstract] [Full Text] [Related]
53. Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic human immunodeficiency virus infection. The Italian Pediatric Collaborative Study Group on Pentamidine. Principi N, Marchisio P, Onorato J, Gabiano C, Galli L, Caselli D, Morandi B, Campelli A, Clerici M, Gattinara GC. J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun 01; 12(2):158-63. PubMed ID: 8680887 [Abstract] [Full Text] [Related]
54. Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia. Ewig S, Schäfer H, Rockstroh JK, Pickenhain A, Lüderitz B. Eur Respir J; 1996 May 01; 9(5):1006-12. PubMed ID: 8793464 [Abstract] [Full Text] [Related]
55. Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis. Freedberg KA, Tosteson AN, Cohen CJ, Cotton DJ. J Acquir Immune Defic Syndr (1988); 1991 May 01; 4(5):521-31. PubMed ID: 1673157 [Abstract] [Full Text] [Related]